CASZ1b enhances T‐ALL cell viability, interacts with NOTCH1 in leukemogenesis, and affects chemotherapy resistance, emphasizing its potential as a therapeutic target [243]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.